Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
The American Journal of Pathology|November 8, 2008
Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpesFaris Farassati, Weihong Pan, Farnaz Yamoutpour, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Distinguishing inflammation from tumor and peritumoral edema by myeloperoxidase magnetic resonance imagingAnne Kleijn, John W Chen, Jason S Buhrman, et al.Targeted Oncology|July 14, 2019
A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade MeningiomaFares Nigim, Juri Kiyokawa, Alessandra Gurtner, et al.Journal of Neuropathology and Experimental Neurology|June 18, 2015
Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor MicroenvironmentFares Nigim, Jill Cavanaugh, Anoop P Patel, et al.Neuro-Oncology Advances|February 3, 2025
Immunocompetent murine glioblastoma stem-like cell models exhibiting distinct phenotypesKimia Kardani, Shanawaz M Ghouse, Muzammil Arif Din Abdul Jabbar, et al.Neuro-Oncology|March 9, 2016
A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virusFares Nigim, Shin-Ichi Esaki, Michael Hood, et al.Scientific Reports|January 16, 2019
Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapyShota Tanaka, Samantha Luk, Juri Kiyokawa, et al.Neuro-Oncology|November 10, 2011
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cellsHiroaki Wakimoto, Gayatry Mohapatra, Ryuichi Kanai, et al.Cancer Letters|August 24, 2023
Photodynamic augmentation of oncolytic virus therapy for central nervous system malignanciesKazuhide Shimizu, Andranik Kahramanian, Muzammil Arif Din Abdul Jabbar, et al.Cancer Research|April 29, 2010
Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replicationBrent J Passer, Tooba Cheema, Bingsen Zhou, et al.Pageof 9